SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-24-001605
Filing Date
2024-01-10
Accepted
2024-01-10 06:16:09
Documents
14
Period of Report
2024-01-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ny20018394x2_8k.htm   iXBRL 8-K 30413
2 EXHIBIT 5.1 ny20018394x2_ex5-1.htm EX-5.1 7681
6 ny20018394x2_dlalogo.jpg GRAPHIC 9519
  Complete submission text file 0001140361-24-001605.txt   189356

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA tlry-20240109.xsd EX-101.SCH 3860
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE tlry-20240109_lab.xml EX-101.LAB 22547
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tlry-20240109_pre.xml EX-101.PRE 16041
8 EXTRACTED XBRL INSTANCE DOCUMENT ny20018394x2_8k_htm.xml XML 4068
Mailing Address 655 MADISON AVENUE 19TH FLOOR NEW YORK NY 10065
Business Address 655 MADISON AVENUE 19TH FLOOR NEW YORK NY 10065 519.322.8800
Tilray Brands, Inc. (Filer) CIK: 0001731348 (see all company filings)

IRS No.: 824310622 | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 001-38594 | Film No.: 24524814
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)